SCP Private Credit Income BDC 10-Q 7 Nov 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 03, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Amendment Flag	false
Document Period End Date	Sep. 30, 2023
Entity Registrant Name	SCP Private Credit Income BDC LLC
Entity Central Index Key	0001743415
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		26,710,775
Entity File Number	814-01294
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	500 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	993-1670
Entity Interactive Data Current	Yes
Entity Tax Identification Number	83-0634992
Entity Ex Transition Period	false

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022
Investments at fair value:
Cash		$ 14,989	$ 16,697
Interest receivable		3,845	3,647
Receivable for investments sold		72	0
Prepaid expenses		54	22
Total assets		533,179	553,261
Liabilities
Distributions payable		0	10,825
Management fee payable (see note 3)		3,238	519
Incentive fee payable (see note 3)		3,325	4,025
Administration fee payable (see note 3)		105	108
Interest payable (see note 5)		4,670	4,041
Other liabilities and accrued expenses		473	940
Total liabilities		265,206	357,007
Commitments and contingencies (see note 6)
Unitholders' Capital
Common Unitholders' capital (25,190,253 and 18,992,563 units, respectively, issued and outstanding)		261,160	196,160
Accumulated distributable earnings		6,813	94
Total unitholders' capital		267,973	196,254
Total liabilities and unitholders' capital		$ 533,179	$ 553,261
Net asset value per unit	[1]	$ 10.64	$ 10.33
SPV Facility [Member]
Liabilities
Revolving credit facility		$ 223,452	$ 266,334
Subscription Facility [Member]
Liabilities
Revolving credit facility		29,943	70,215
Companies Less Than 5% Owned [Member]
Investments at fair value:
Investments at fair value		500,654	532,895
Companies 5% To 25% Owned [Member]
Investments at fair value:
Investments at fair value		$ 13,565	$ 0
[1]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023		Dec. 31, 2022
Common unit issued	25,190,253		18,992,563
Common unit outstanding	25,190,253	[1]	18,992,563
SPV Facility [Member]
Debt Instrument face amount	$ 223,800		$ 267,726
Net of unamortized debt issuance costs	348		1,392
Subscription Facility [Member]
Debt Instrument face amount	30,000		70,400
Net of unamortized debt issuance costs	57		185
Companies Less Than 5% Owned [Member]
Investments at cost	497,210		529,070
Companies 5% To 25% Owned [Member]
Investments at cost	$ 21,469		$ 0
[1]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Investment Income:
Total investment income	$ 15,774	$ 11,797	$ 45,877	$ 30,062
Expenses:
Management fees (see note 3)	1,102	1,010	3,238	2,770
Incentive fees (see note 3)	1,285	958	2,339	2,544
Administration fees (see note 3)	105	102	315	283
Interest and other credit facility expenses (see note 5)	5,722	4,464	17,824	10,268
Other general and administrative expenses	172	207	694	658
Total expenses	8,386	6,741	24,410	16,523
Net investment income	7,388	5,056	21,467	13,539
Realized and unrealized gain (loss) on investments:
Net realized gain on companies less than 5% owned	0	0	74	0
Net change in unrealized gain (loss) on investments	(104)	372	(8,285)	879
Net realized and unrealized gain (loss) on investments	(104)	372	(8,211)	879
Net increase in unitholders' capital resulting from operations	$ 7,284	$ 5,428	$ 13,256	$ 14,418
Net Income Per Unit	$ 0.29	$ 0.29	$ 0.55	$ 0.81
Companies Less Than 5% Owned [Member]
Investment Income:
Interest:	$ 15,658	$ 11,749	$ 45,294	$ 29,844
Other income:	103	48	570	218
Realized and unrealized gain (loss) on investments:
Net realized gain on companies less than 5% owned	0	0	74	0
Net change in unrealized gain (loss) on investments	(1,045)	372	(7,155)	879
Companies 5% To 25% Owned [Member]
Investment Income:
Interest:	13	0	13	0
Realized and unrealized gain (loss) on investments:
Net change in unrealized gain (loss) on investments	$ 941	$ 0	$ (1,130)	$ 0

Consolidated Statement of Chang

Consolidated Statement of Changes in Unitholders' Capital - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Increase (decrease) in unitholders' capital resulting from operations:
Net investment income		$ 7,388	$ 5,056	$ 21,467	$ 13,539
Net realized gain		0	0	74	0
Net change in unrealized gain (loss)		(104)	372	(8,285)	879
Net increase in unitholders' capital resulting from operations		7,284	5,428	13,256	14,418
Distributions to unitholders:
From net investment income		(6,537)	(4,528)	(6,537)	(4,528)
Increase in unitholders' capital resulting from capital activity:
Contributions		0	0	65,000	20,000
Net increase in unitholders' capital resulting from capital activity		0	0	65,000	20,000
Total increase in unitholders' capital		747	900	71,719	29,890
Unitholders' capital, beginning of period		267,226	205,103	196,254	176,113
Unitholders' capital, end of period	[1]	$ 267,973	$ 206,003	$ 267,973	$ 206,003
Units issued		0	0	6,197,690	1,855,288
Net increase from capital unit activity		0	0	6,197,690	1,855,288
[1]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net increase in unitholders' capital resulting from operations	$ 13,256	$ 14,418
Adjustments to reconcile net increase in unitholders' capital resulting from operations to net cash provided by (used in) operating activities:
Net realized gain on investments	(74)	0
Net change in unrealized (gain) loss on investments	8,285	(879)
Deferred financing costs	1,204	1,275
(Increase) decrease in operating assets:
Purchase of investments	(82,937)	(137,266)
Net accretion of discount on investments	(2,511)	(1,779)
Proceeds from disposition of investments	97,423	38,182
Capitalization of payment-in-kind income	(1,510)	(461)
Receivable for investments sold	(72)	(120)
Interest receivable	(198)	(938)
Prepaid expenses	(32)	(39)
Increase (decrease) in operating liabilities:
Management fee payable	2,719	2,770
Incentive fee payable	(700)	219
Administration fee payable	(3)	23
Interest payable	629	1,836
Other liabilities and accrued expenses	(467)	111
Net Cash Provided by (Used in) Operating Activities	35,012	(82,648)
Cash Flows from Financing Activities:
Contributions from unitholders	65,000	20,000
Cash distributions paid	(17,362)	(11,805)
Proceeds from borrowings	46,768	148,010
Repayments of borrowings	(131,126)	(73,400)
Net Cash Provided by (Used in) Financing Activities	(36,720)	82,805
NET INCREASE (DECREASE) IN CASH	(1,708)	157
CASH AT BEGINNING OF PERIOD	16,697	11,181
CASH AT END OF PERIOD	14,989	11,338
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 17,195	$ 8,432

Consolidated Schedule of Invest

Consolidated Schedule of Investments - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
		Sep. 30, 2023		Dec. 31, 2022
Total Investments — 191.9%
Summary of Investment Holdings [Line Items]
Cost	[1]	$ 518,679
Fair Value	[1]	514,219
Liabilities in Excess of Other Assets — (91.9%)
Summary of Investment Holdings [Line Items]
Liabilities in Excess of Other Assets		(246,246)
Total Investments — 271.5%
Summary of Investment Holdings [Line Items]
Cost	[2]			$ 529,070
Fair Value	[2]			532,895
Liabilities in Excess of Other Assets — (171.5%)
Summary of Investment Holdings [Line Items]
Liabilities in Excess of Other Assets				(336,641)
Net Assets — 100.0%
Summary of Investment Holdings [Line Items]
Net Assets		267,973		196,254
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans
Summary of Investment Holdings [Line Items]
Cost		501,012		528,920
Fair Value		$ 500,850		$ 532,753
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | ACRES Commercial Mortgage LLC | Diversified Financial Services | S+705 | 1.00% | 11.38% | 12/24/2021 | 8/21/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			705%
Floor	[4]			1%
Interest Rate	[4],[5]			11.38%
Acquisition Date	[4]			Dec. 24, 2021
Maturity Date	[4]			Aug. 21, 2028
Par Amount	[4]			$ 12,660
Cost	[4]			12,437
Fair Value	[4]			$ 12,660
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | ACRES Commercial Mortgage, LLC | Diversified Financial Services | S+705 | 1.00 | 12.49 | 12/24/2021 | 8/21/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	705%
Floor	[4]	1%
Interest Rate	[4],[6]	12.49%
Acquisition Date	[4]	Dec. 24, 2021
Maturity Date	[4]	Aug. 21, 2028
Par Amount	[4]	$ 12,660
Cost	[4]	12,461
Fair Value	[4]	$ 12,660
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) | Insurance | S+550 | 0.75 | 11.02 | 10/5/2020 | 11/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	0.75%
Interest Rate	[4],[6]	11.02%
Acquisition Date	[4]	Oct. 05, 2020
Maturity Date	[4]	Nov. 01, 2026
Par Amount	[4]	$ 19,553
Cost	[4]	19,333
Fair Value	[4]	$ 19,553
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Alimera Sciences Inc. | Pharmaceuticals | L+765 | 1.78% | 11.82% | 12/31/2019 | 7/1/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			765%
Floor	[4]			1.78%
Interest Rate	[4],[5]			11.82%
Acquisition Date	[4]			Dec. 31, 2019
Maturity Date	[4]			Jul. 01, 2024
Par Amount	[4]			$ 3,929
Cost	[4]			4,059
Fair Value	[4]			$ 4,145
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Alimera Sciences, Inc. | Pharmaceuticals | S+515 | 4.60 | 10.48 | 12/31/2019 | 5/1/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	515%
Floor	[4]	4.60%
Interest Rate	[4],[6]	10.48%
Acquisition Date	[4]	Dec. 31, 2019
Maturity Date	[4]	May 01, 2028
Par Amount	[4]	$ 5,893
Cost	[4]	5,919
Fair Value	[4]	$ 6,066
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | All States Ag Parts LLC | Trading Companies & Distributors | S+575 | 1.00% | 10.19% | 9/1/2021 | 9/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			1%
Interest Rate	[4],[5]			10.19%
Acquisition Date	[4]			Sep. 01, 2021
Maturity Date	[4]			Sep. 01, 2026
Par Amount	[4]			$ 5,358
Cost	[4]			5,279
Fair Value	[4]			$ 5,358
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | All States Ag Parts, LLC | Trading Companies & Distributors | S+600 | 1.00 | 11.60 | 9/1/2021 | 9/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	600%
Floor	[4]	1%
Interest Rate	[4],[6]	11.60%
Acquisition Date	[4]	Sep. 01, 2021
Maturity Date	[4]	Sep. 01, 2026
Par Amount	[4]	$ 5,178
Cost	[4]	5,116
Fair Value	[4]	$ 5,178
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | AmeriMark Intermediate Holdings LLC | Internet & Catalog Retail | L+800 | 1.00% | 14.77% | 7/28/2021 | 10/15/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[7]			800%
Floor	[4],[7]			1%
Interest Rate	[4],[5],[7]			14.77%
Acquisition Date	[4],[7]			Jul. 28, 2021
Maturity Date	[4],[7]			Oct. 15, 2026
Par Amount	[4],[7]			$ 21,189
Cost	[4],[7]			20,858
Fair Value	[4],[7]			$ 20,129
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Apex Service Partners LLC | Diversified Consumer Services | S+525 | 1.00% | 9.42% | 11/5/2021 | 7/31/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			525%
Floor	[4]			1%
Interest Rate	[4],[5]			9.42%
Acquisition Date	[4]			Nov. 05, 2021
Maturity Date	[4]			Jul. 31, 2025
Par Amount	[4]			$ 21,450
Cost	[4]			21,134
Fair Value	[4]			$ 21,450
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Apex Service Partners, LLC | Diversified Consumer Services | S+525 | 1.00 | 10.67 | 11/5/2021 | 7/31/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	525%
Floor	[4]	1%
Interest Rate	[4],[6]	10.67%
Acquisition Date	[4]	Nov. 05, 2021
Maturity Date	[4]	Jul. 31, 2025
Par Amount	[4]	$ 20,699
Cost	[4]	20,478
Fair Value	[4]	$ 20,699
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Arcutis Biotherapeutics Inc. | Pharmaceuticals | L+745 | 0.10% | 11.62% | 12/22/2021 | 1/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[8]			745%
Floor	[4],[8]			0.10%
Interest Rate	[4],[5],[8]			11.62%
Acquisition Date	[4],[8]			Dec. 22, 2021
Maturity Date	[4],[8]			Jan. 01, 2027
Par Amount	[4],[8]			$ 24,520
Cost	[4],[8]			24,654
Fair Value	[4],[8]			$ 24,827
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Arcutis Biotherapeutics, Inc. | Pharmaceuticals | S+745 | 0.10 | 12.88 | 12/22/2021 | 1/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[9]	745%
Floor	[4],[9]	0.10%
Interest Rate	[4],[6],[9]	12.88%
Acquisition Date	[4],[9]	Dec. 22, 2021
Maturity Date	[4],[9]	Jan. 01, 2027
Par Amount	[4],[9]	$ 24,520
Cost	[4],[9]	24,945
Fair Value	[4],[9]	$ 24,950
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Ardelyx Inc. | Pharmaceuticals | L+795 | 0.10% | 12.12% | 2/23/2022 | 3/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[8]			795%
Floor	[4],[8]			0.10%
Interest Rate	[4],[5],[8]			12.12%
Acquisition Date	[4],[8]			Feb. 23, 2022
Maturity Date	[4],[8]			Mar. 01, 2027
Par Amount	[4],[8]			$ 3,319
Cost	[4],[8]			3,328
Fair Value	[4],[8]			$ 3,328
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Ardelyx, Inc. | Pharmaceuticals | S+795 | 1.00 | 13.30 | 2/23/2022 | 3/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[9]	795%
Floor	[4],[9]	1%
Interest Rate	[4],[6],[9]	13.30%
Acquisition Date	[4],[9]	Feb. 23, 2022
Maturity Date	[4],[9]	Mar. 01, 2027
Par Amount	[4],[9]	$ 3,319
Cost	[4],[9]	3,356
Fair Value	[4],[9]	$ 3,423
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Basic Fun Inc. | Specialty Retail | L+550 | 1.00% | 10.27% | 10/30/2020 | 10/30/2023
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			1%
Interest Rate	[4],[5]			10.27%
Acquisition Date	[4]			Oct. 30, 2020
Maturity Date	[4]			Oct. 30, 2023
Par Amount	[4]			$ 966
Cost	[4]			961
Fair Value	[4]			$ 966
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Basic Fun, Inc. | Specialty Retail | S+650 | 1.00 | 12.17 | 10/30/2020 | 7/2/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	650%
Floor	[4]	1%
Interest Rate	[4],[6]	12.17%
Acquisition Date	[4]	Oct. 30, 2020
Maturity Date	[4]	Jul. 02, 2024
Par Amount	[4]	$ 960
Cost	[4]	960
Fair Value	[4]	$ 960
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | BayMark Health Services Inc. | Health Care Providers & Services | L+500 | 1.00% | 9.73% | 6/29/2021 | 6/11/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			500%
Floor	[4]			1%
Interest Rate	[4],[5]			9.73%
Acquisition Date	[4]			Jun. 29, 2021
Maturity Date	[4]			Jun. 11, 2027
Par Amount	[4]			$ 15,861
Cost	[4]			15,733
Fair Value	[4]			$ 15,861
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | BayMark Health Services, Inc. | Health Care Providers & Services | S+500 | 1.00 | 10.65 | 6/29/2021 | 6/11/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	500%
Floor	[4]	1%
Interest Rate	[4],[6]	10.65%
Acquisition Date	[4]	Jun. 29, 2021
Maturity Date	[4]	Jun. 11, 2027
Par Amount	[4]	$ 15,741
Cost	[4]	15,632
Fair Value	[4]	$ 15,741
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | BridgeBio Pharma Inc. | Biotechnology | 9.00% | 11/17/2021 | 11/17/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[8]			0%
Floor	[4],[8]			0%
Interest Rate	[4],[5],[8],[10]			9%
Acquisition Date	[4],[8]			Nov. 17, 2021
Maturity Date	[4],[8]			Nov. 17, 2026
Par Amount	[4],[8]			$ 14,362
Cost	[4],[8]			14,257
Fair Value	[4],[8]			$ 14,362
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | BridgeBio Pharma, Inc. | Biotechnology | 9.00 | 11/17/2021 | 11/17/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[9]	0%
Floor	[4],[9]	0%
Interest Rate	[4],[6],[9],[10]	9%
Acquisition Date	[4],[9]	Nov. 17, 2021
Maturity Date	[4],[9]	Nov. 17, 2026
Par Amount	[4],[9]	$ 14,691
Cost	[4],[9]	14,658
Fair Value	[4],[9]	$ 14,728
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | L+575 | 0.75% | 10.48% | 6/29/2021 | 6/29/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			0.75%
Interest Rate	[4],[5]			10.48%
Acquisition Date	[4]			Jun. 29, 2021
Maturity Date	[4]			Jun. 29, 2028
Par Amount	[4]			$ 6,491
Cost	[4]			6,407
Fair Value	[4]			$ 6,491
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | S+575 | 0.75 | 11.18 | 6/29/2021 | 6/29/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	575%
Floor	[4]	0.75%
Interest Rate	[4],[6]	11.18%
Acquisition Date	[4]	Jun. 29, 2021
Maturity Date	[4]	Jun. 29, 2028
Par Amount	[4]	$ 12,577
Cost	[4]	12,416
Fair Value	[4]	$ 12,577
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Centrexion Therapeutics Inc. | Pharmaceuticals | L+725 | 2.45% | 11.42% | 6/28/2019 | 1/1/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3]			725%
Floor				2.45%
Interest Rate	[5]			11.42%
Acquisition Date				Jun. 28, 2019
Maturity Date				Jan. 01, 2024
Par Amount				$ 2,314
Cost				2,417
Fair Value				$ 2,453
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Cerapedics Inc. | Biotechnology | S+620 | 2.75% | 10.52% | 12/27/2022 | 1/1/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			620%
Floor	[4]			2.75%
Interest Rate	[4],[5]			10.52%
Acquisition Date	[4]			Dec. 27, 2022
Maturity Date	[4]			Jan. 01, 2028
Par Amount	[4]			$ 9,698
Cost	[4]			9,674
Fair Value	[4]			$ 9,673
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Cerapedics, Inc. | Biotechnology | S+620 | 2.75 | 11.53 | 12/27/2022 | 1/1/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	620%
Floor	[4]	2.75%
Interest Rate	[4],[6]	11.53%
Acquisition Date	[4]	Dec. 27, 2022
Maturity Date	[4]	Jan. 01, 2028
Par Amount	[4]	$ 9,698
Cost	[4]	9,720
Fair Value	[4]	$ 9,722
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) | Trading Companies & Distributors | S+475 | 1.00 | 10.24 | 12/31/2019 | 12/31/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	475%
Floor	[4]	1%
Interest Rate	[4],[6]	10.24%
Acquisition Date	[4]	Dec. 31, 2019
Maturity Date	[4]	Dec. 31, 2025
Par Amount	[4]	$ 7,127
Cost	[4]	7,068
Fair Value	[4]	$ 7,127
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) | Trading Companies & Distributors | S+475 | 1.00% | 9.43% | 12/31/2019 | 12/31/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			475%
Floor	[4]			1%
Interest Rate	[4],[5]			9.43%
Acquisition Date	[4]			Dec. 31, 2019
Maturity Date	[4]			Dec. 31, 2025
Par Amount	[4]			$ 7,570
Cost	[4]			7,490
Fair Value	[4]			$ 7,570
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Enhanced Permanent Capital LLC | Capital Markets | L+700 | 1.00% | 10.13% | 12/29/2020 | 12/29/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[8]			700%
Floor	[4],[8]			1%
Interest Rate	[4],[5],[8]			10.13%
Acquisition Date	[4],[8]			Dec. 29, 2020
Maturity Date	[4],[8]			Dec. 29, 2025
Par Amount	[4],[8]			$ 7,503
Cost	[4],[8]			7,352
Fair Value	[4],[8]			$ 7,503
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Enhanced Permanent Capital, LLC | Capital Markets | S+700 | 1.00 | 12.26 | 12/29/2020 | 12/29/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[9]	700%
Floor	[4],[9]	1%
Interest Rate	[4],[6],[9]	12.26%
Acquisition Date	[4],[9]	Dec. 29, 2020
Maturity Date	[4],[9]	Dec. 29, 2025
Par Amount	[4],[9]	$ 9,062
Cost	[4],[9]	8,907
Fair Value	[4],[9]	$ 9,062
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Enverus Holdings Inc. (fka Drilling Info Holdings) | IT Services | L+450 | 8.88% | 1/31/2020 | 7/30/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			450%
Floor	[4]			0%
Interest Rate	[4],[5]			8.88%
Acquisition Date	[4]			Jan. 31, 2020
Maturity Date	[4]			Jul. 30, 2025
Par Amount	[4]			$ 14,454
Cost	[4]			14,252
Fair Value	[4]			$ 14,454
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Enverus Holdings, Inc. (fka Drilling Info Holdings) | IT Services | S+450 | 9.92 | 1/31/2020 | 7/30/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	450%
Floor	[4]	0%
Interest Rate	[4],[6]	9.92%
Acquisition Date	[4]	Jan. 31, 2020
Maturity Date	[4]	Jul. 30, 2025
Par Amount	[4]	$ 14,053
Cost	[4]	13,910
Fair Value	[4]	$ 14,053
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Erie Construction Mid-west LLC | Building Products | S+475 | 1.00% | 9.79% | 8/5/2021 | 7/30/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			475%
Floor	[4]			1%
Interest Rate	[4],[5]			9.79%
Acquisition Date	[4]			Aug. 05, 2021
Maturity Date	[4]			Jul. 30, 2027
Par Amount	[4]			$ 11,381
Cost	[4]			11,222
Fair Value	[4]			$ 11,381
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Erie Construction Mid-west, LLC | Building Products | S+475 | 1.00 | 10.34 | 8/5/2021 | 7/30/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	475%
Floor	[4]	1%
Interest Rate	[4],[6]	10.34%
Acquisition Date	[4]	Aug. 05, 2021
Maturity Date	[4]	Jul. 30, 2027
Par Amount	[4]	$ 10,943
Cost	[4]	10,813
Fair Value	[4]	$ 10,943
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Fertility (ITC) Investment Holdco, LLC | Health Care Providers & Services | S+650 | 1.00 | 1/4/2023 | 1/3/2029
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	650%
Floor	[4]	1%
Interest Rate	[4],[6]	11.63%
Acquisition Date	[4]	Jan. 04, 2023
Maturity Date	[4]	Jan. 03, 2029
Par Amount	[4]	$ 10,304
Cost	[4]	10,022
Fair Value	[4]	$ 10,304
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Foundation Consumer Brands LLC | Personal Products | L+550 | 1.00% | 10.15% | 2/12/2021 | 2/12/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			1%
Interest Rate	[4],[5]			10.15%
Acquisition Date	[4]			Feb. 12, 2021
Maturity Date	[4]			Feb. 12, 2027
Par Amount	[4]			$ 12,288
Cost	[4]			12,063
Fair Value	[4]			$ 12,288
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Foundation Consumer Brands, LLC | Personal Products | S+625 | 1.00 | 11.77 | 2/12/2021 | 2/12/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	625%
Floor	[4]	1%
Interest Rate	[4],[6]	11.77%
Acquisition Date	[4]	Feb. 12, 2021
Maturity Date	[4]	Feb. 12, 2027
Par Amount	[4]	$ 11,721
Cost	[4]	11,540
Fair Value	[4]	$ 11,721
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1.00 | 10.65 | 4/20/2021 | 11/16/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	500%
Floor	[4]	1%
Interest Rate	[4],[6]	10.65%
Acquisition Date	[4]	Apr. 20, 2021
Maturity Date	[4]	Nov. 16, 2026
Par Amount	[4]	$ 13,963
Cost	[4]	13,875
Fair Value	[4]	$ 13,963
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1.00% | 9.03% | 4/20/2021 | 11/16/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			500%
Floor	[4]			1%
Interest Rate	[4],[5]			9.03%
Acquisition Date	[4]			Apr. 20, 2021
Maturity Date	[4]			Nov. 16, 2026
Par Amount	[4]			$ 14,069
Cost	[4]			13,961
Fair Value	[4]			$ 13,928
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Glooko Inc. | Health Care Technology | L+790 | 0.10% | 12.07% | 9/30/2021 | 10/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			790%
Floor	[4]			0.10%
Interest Rate	[4],[5]			12.07%
Acquisition Date	[4]			Sep. 30, 2021
Maturity Date	[4]			Oct. 01, 2026
Par Amount	[4]			$ 2,831
Cost	[4]			2,838
Fair Value	[4]			$ 2,838
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Glooko, Inc. | Health Care Technology | S+790 | 0.10 | 13.33 | 9/30/2021 | 10/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	790%
Floor	[4]	0.10%
Interest Rate	[4],[6]	13.33%
Acquisition Date	[4]	Sep. 30, 2021
Maturity Date	[4]	Oct. 01, 2026
Par Amount	[4]	$ 2,123
Cost	[4]	2,145
Fair Value	[4]	$ 2,165
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Higginbotham Insurance Agency Inc. | Insurance | L+525 | 0.75% | 9.63% | 11/25/2020 | 11/25/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			525%
Floor	[4]			0.75%
Interest Rate	[4],[5]			9.63%
Acquisition Date	[4]			Nov. 25, 2020
Maturity Date	[4]			Nov. 25, 2026
Par Amount	[4]			$ 8,130
Cost	[4]			8,043
Fair Value	[4]			$ 8,130
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | High Street Buyer Inc. | Insurance | L+600 | 0.75% | 8.75% | 4/16/2021 | 4/16/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			600%
Floor	[4]			0.75%
Interest Rate	[4],[5]			8.75%
Acquisition Date	[4]			Apr. 16, 2021
Maturity Date	[4]			Apr. 16, 2028
Par Amount	[4]			$ 11,606
Cost	[4]			11,408
Fair Value	[4]			$ 11,606
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | High Street Buyer, Inc | Insurance | S+600 | 0.75 | 11.29 | 4/16/2021 | 4/16/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	600%
Floor	[4]	0.75%
Interest Rate	[4],[6]	11.29%
Acquisition Date	[4]	Apr. 16, 2021
Maturity Date	[4]	Apr. 16, 2028
Par Amount	[4]	$ 12,007
Cost	[4]	11,824
Fair Value	[4]	$ 12,007
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Human Interest Inc. | Internet Software & Services | S+785 | 1.00 | 13.18 | 6/30/2022 | 7/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	785%
Floor	[4]	1%
Interest Rate	[4],[6]	13.18%
Acquisition Date	[4]	Jun. 30, 2022
Maturity Date	[4]	Jul. 01, 2027
Par Amount	[4]	$ 6,799
Cost	[4]	6,731
Fair Value	[4]	$ 6,799
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Human Interest Inc. | Internet Software & Services | S+785 | 1.00% | 11.97% | 6/30/2022 | 7/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			785%
Floor	[4]			1%
Interest Rate	[4],[5]			11.97%
Acquisition Date	[4]			Jun. 30, 2022
Maturity Date	[4]			Jul. 01, 2027
Par Amount	[4]			$ 6,799
Cost	[4]			6,690
Fair Value	[4]			$ 6,799
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Ivy Fertility Services LLC | Health Care Providers & Services | L+625 | 1.00% | 10.39% | 12/22/2021 | 2/25/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			625%
Floor	[4]			1%
Interest Rate	[4],[5]			10.39%
Acquisition Date	[4]			Dec. 22, 2021
Maturity Date	[4]			Feb. 25, 2026
Par Amount	[4]			$ 10,515
Cost	[4]			10,369
Fair Value	[4]			$ 10,620
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | KORE Wireless Group Inc. | Wireless Telecommunication Services | S+550 | 10.08% | 3/12/2019 | 12/21/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			0%
Interest Rate	[4],[5]			10.08%
Acquisition Date	[4]			Mar. 12, 2019
Maturity Date	[4]			Dec. 21, 2024
Par Amount	[4]			$ 14,104
Cost	[4]			13,992
Fair Value	[4]			$ 14,104
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | KORE Wireless Group, Inc. | Wireless Telecommunication Services | S+550 | 10.99 | 3/12/2019 | 12/21/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	0%
Interest Rate	[4],[6]	10.99%
Acquisition Date	[4]	Mar. 12, 2019
Maturity Date	[4]	Dec. 21, 2024
Par Amount	[4]	$ 13,993
Cost	[4]	13,923
Fair Value	[4]	$ 13,993
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Kaseya Inc. | Software | S+575 | 0.75% | 10.33% | 6/22/2022 | 6/23/2029
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			0.75%
Interest Rate	[4],[5]			10.33%
Acquisition Date	[4]			Jun. 22, 2022
Maturity Date	[4]			Jun. 23, 2029
Par Amount	[4]			$ 10,966
Cost	[4]			10,810
Fair Value	[4]			$ 10,966
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Kaseya, Inc | Software | S+625 | 0.75 | 11.62 | 6/22/2022 | 6/23/2029
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	625%
Floor	[4]	0.75%
Interest Rate	[4],[6],[11]	11.62%
Acquisition Date	[4]	Jun. 22, 2022
Maturity Date	[4]	Jun. 23, 2029
Par Amount	[4]	$ 11,030
Cost	[4]	10,888
Fair Value	[4]	$ 11,030
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Kid Distro Holdings LLC (Distro Kid) | Software | L+575 | 1.00% | 10.48% | 9/24/2021 | 10/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			1%
Interest Rate	[4],[5]			10.48%
Acquisition Date	[4]			Sep. 24, 2021
Maturity Date	[4]			Oct. 01, 2027
Par Amount	[4]			$ 12,457
Cost	[4]			12,251
Fair Value	[4]			$ 12,457
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Kid Distro Holdings, LLC (Distro Kid) | Software | S+550 | 1.00 | 11.04 | 9/24/2021 | 10/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	1%
Interest Rate	[4],[6]	11.04%
Acquisition Date	[4]	Sep. 24, 2021
Maturity Date	[4]	Oct. 01, 2027
Par Amount	[4]	$ 12,362
Cost	[4]	12,185
Fair Value	[4]	$ 12,362
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | MRI Software LLC | Software | L+550 | 1.00% | 10.23% | 7/23/2019 | 2/10/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			1%
Interest Rate	[4],[5]			10.23%
Acquisition Date	[4]			Jul. 23, 2019
Maturity Date	[4]			Feb. 10, 2026
Par Amount	[4]			$ 15,308
Cost	[4]			15,180
Fair Value	[4]			$ 15,308
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | MRI Software LLC | Software | S+550 | 1.00 | 10.99 | 7/23/2019 | 2/10/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	1%
Interest Rate	[4],[6]	10.99%
Acquisition Date	[4]	Jul. 23, 2019
Maturity Date	[4]	Feb. 10, 2026
Par Amount	[4]	$ 15,191
Cost	[4]	15,092
Fair Value	[4]	$ 15,191
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Maurices Incorporated | Specialty Retail | S+675 | 1.00% | 8.74% | 8/27/2021 | 6/1/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	675%		675%
Floor	[4]	1%		1%
Interest Rate	[4]	9.94%	[6]	8.74%	[5]
Acquisition Date	[4]	Aug. 27, 2021		Aug. 27, 2021
Maturity Date	[4]	Jun. 01, 2024		Jun. 01, 2024
Par Amount	[4]	$ 4,685		$ 4,947
Cost	[4]	4,678		4,891
Fair Value	[4]	$ 4,685		$ 4,947
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Meditrina Inc. | Health Care Equipment & Supplies | S+550 | 3.45% | 9.82% | 12/20/2022 | 12/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%		550%
Floor	[4]	3.45%		3.45%
Interest Rate	[4]	10.83%	[6]	9.82%	[5]
Acquisition Date	[4]	Dec. 20, 2022		Dec. 20, 2022
Maturity Date	[4]	Dec. 01, 2027		Dec. 01, 2027
Par Amount	[4]	$ 1,212		$ 1,212
Cost	[4]	1,211		1,201
Fair Value	[4]	$ 1,218		$ 1,209
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | NAC Holding Corporation (Jaguar) | Insurance | S+525 | 1.00% | 9.45% | 7/30/2021 | 9/28/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			525%
Floor	[4]			1%
Interest Rate	[4],[5]			9.45%
Acquisition Date	[4]			Jul. 30, 2021
Maturity Date	[4]			Sep. 28, 2024
Par Amount	[4]			$ 12,461
Cost	[4]			12,355
Fair Value	[4]			$ 12,461
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Neuronetics Inc. | Health Care Equipment & Supplies | L+765 | 1.66% | 11.82% | 3/2/2020 | 2/28/2025
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			765%
Floor	[4]			1.66%
Interest Rate	[4],[5]			11.82%
Acquisition Date	[4]			Mar. 02, 2020
Maturity Date	[4]			Feb. 28, 2025
Par Amount	[4]			$ 3,056
Cost	[4]			3,143
Fair Value	[4]			$ 3,224
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Neuronetics, Inc. | Health Care Equipment & Supplies | S+565 | 3.95 | 10.98 | 3/2/2020 | 3/29/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	565%
Floor	[4]	3.95%
Interest Rate	[4],[6]	10.98%
Acquisition Date	[4]	Mar. 02, 2020
Maturity Date	[4]	Mar. 29, 2028
Par Amount	[4]	$ 3,274
Cost	[4]	3,280
Fair Value	[4]	$ 3,290
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Nexus Intermediate III LLC (Vortex) | Professional Services | L+550 | 0.75% | 10.22% | 12/13/2021 | 12/6/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			0.75%
Interest Rate	[4],[5]			10.22%
Acquisition Date	[4]			Dec. 13, 2021
Maturity Date	[4]			Dec. 06, 2027
Par Amount	[4]			$ 5,947
Cost	[4]			5,858
Fair Value	[4]			$ 5,947
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Nexus Intermediate III, LLC (Vortex) | Professional Services | S+550 | 0.75 | 11.36 | 12/13/2021 | 12/6/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	0.75%
Interest Rate	[4],[6]	11.36%
Acquisition Date	[4]	Dec. 13, 2021
Maturity Date	[4]	Dec. 06, 2027
Par Amount	[4]	$ 5,396
Cost	[4]	5,326
Fair Value	[4]	$ 5,396
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Oldco AI, LLC (f/k/a AmeriMark) | Internet & Catalog Retail | P+475 | 1.00 | 13.25 | 6/16/2023 | 10/31/2023
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[12],[13]	475%
Floor	[12],[13]	1%
Interest Rate	[6],[12],[13]	13.25%
Acquisition Date	[12],[13]	Jun. 16, 2023
Maturity Date	[12],[13]	Oct. 31, 2023
Par Amount	[12],[13]	$ 282
Cost	[12],[13]	282
Fair Value	[12],[13]	$ 282
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Oldco AI, LLC (f/k/a AmeriMark) | Internet & Catalog Retail | S+800 | 1.00 | 7/28/2021 | 10/15/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[12],[13],[14]	800%
Floor	[4],[12],[13],[14]	1%
Interest Rate	[4],[6],[12],[13],[14]	0%
Acquisition Date	[4],[12],[13],[14]	Jul. 28, 2021
Maturity Date	[4],[12],[13],[14]	Oct. 15, 2026
Par Amount	[4],[12],[13],[14]	$ 4,271
Cost	[4],[12],[13],[14]	3,698
Fair Value	[4],[12],[13],[14]	$ 0
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Oral Surgery Partners Holdings LLC | Health Care Providers & Services | S+625 | 1.00% | 10.92% | 11/29/2022 | 5/10/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3]			625%
Floor				1%
Interest Rate	[5]			10.92%
Acquisition Date				Nov. 29, 2022
Maturity Date				May 10, 2024
Par Amount				$ 2,206
Cost				2,164
Fair Value				$ 2,162
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management LLC | Health Care Providers & Services | S+650 | 1.00% | 10.91% | 8/17/2022 | 5/16/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			650%
Floor	[4]			1%
Interest Rate	[4],[5]			10.91%
Acquisition Date	[4]			Aug. 17, 2022
Maturity Date	[4]			May 16, 2024
Par Amount	[4]			$ 4,226
Cost	[4]			4,200
Fair Value	[4]			$ 4,226
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management, LLC | Health Care Providers & Services | S+650 | 1.00 | 11.96 | 8/17/2022 | 5/16/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	650%
Floor	[4]	1%
Interest Rate	[4],[6]	11.96%
Acquisition Date	[4]	Aug. 17, 2022
Maturity Date	[4]	May 16, 2024
Par Amount	[4]	$ 6,385
Cost	[4]	6,362
Fair Value	[4]	$ 6,290
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Outset Medical Inc. | Health Care Providers & Services | S+515 | 2.75% | 9.33% | 11/3/2022 | 12/4/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[8]			515%
Floor	[4],[8]			2.75%
Interest Rate	[4],[5],[8]			9.33%
Acquisition Date	[4],[8]			Nov. 03, 2022
Maturity Date	[4],[8]			Nov. 01, 2027
Par Amount	[4],[8]			$ 11,865
Cost	[4],[8]			11,796
Fair Value	[4],[8]			$ 11,775
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75 | 10.48 | 11/3/2022 | 11/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4],[9]	515%
Floor	[4],[9]	2.75%
Interest Rate	[4],[6],[9]	10.48%
Acquisition Date	[4],[9]	Nov. 03, 2022
Maturity Date	[4],[9]	Nov. 01, 2027
Par Amount	[4],[9]	$ 11,865
Cost	[4],[9]	11,891
Fair Value	[4],[9]	$ 11,894
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Pediatric Home Respiratory Services LLC | Health Care Providers & Services | S+625 | 1.00% | 10.67% | 8/19/2022 | 12/4/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			625%
Floor	[4]			1%
Interest Rate	[4],[5]			10.67%
Acquisition Date	[4]			Aug. 19, 2022
Maturity Date	[4]			Dec. 04, 2024
Par Amount	[4]			$ 1,802
Cost	[4]			1,778
Fair Value	[4]			$ 1,784
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Pediatric Home Respiratory Services, LLC | Health Care Providers & Services | S+625 | 1.00 | 11.67 | 8/19/2022 | 12/4/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	625%
Floor	[4]	1%
Interest Rate	[4],[6]	11.67%
Acquisition Date	[4]	Aug. 19, 2022
Maturity Date	[4]	Dec. 04, 2024
Par Amount	[4]	$ 4,235
Cost	[4]	4,186
Fair Value	[4]	$ 4,235
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services LLC | Insurance | S+600 | 0.75% | 11.21% | 10/29/2021 | 11/1/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			600%
Floor	[4]			0.75%
Interest Rate	[4],[5]			11.21%
Acquisition Date	[4]			Oct. 29, 2021
Maturity Date	[4]			Nov. 01, 2028
Par Amount	[4]			$ 15,579
Cost	[4]			15,444
Fair Value	[4]			$ 15,579
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+600 | 0.75 | 11.43 | 10/29/2021 | 11/1/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	600%
Floor	[4]	0.75%
Interest Rate	[4],[6]	11.43%
Acquisition Date	[4]	Oct. 29, 2021
Maturity Date	[4]	Nov. 01, 2028
Par Amount	[4]	$ 15,461
Cost	[4]	15,341
Fair Value	[4]	$ 15,152
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers Inc. | Health Care Providers & Services | S+650 | 1.00% | 10.57% | 1/22/2020 | 1/2/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			650%
Floor	[4]			1%
Interest Rate	[4],[5]			10.57%
Acquisition Date	[4]			Jan. 22, 2020
Maturity Date	[4]			Jan. 02, 2026
Par Amount	[4]			$ 8,339
Cost	[4]			8,233
Fair Value	[4]			$ 8,152
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | S+675 | 1.00 | 12.32 | 1/22/2020 | 1/2/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	675%
Floor	[4]	1%
Interest Rate	[4],[6]	12.32%
Acquisition Date	[4]	Jan. 22, 2020
Maturity Date	[4]	Jan. 02, 2026
Par Amount	[4]	$ 8,275
Cost	[4]	8,196
Fair Value	[4]	$ 8,275
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Plastics Management LLC | Health Care Providers & Services | S+500 | 1.00% | 9.89% | 8/26/2021 | 8/18/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			500%
Floor	[4]			1%
Interest Rate	[4],[5]			9.89%
Acquisition Date	[4]			Aug. 26, 2021
Maturity Date	[4]			Aug. 18, 2027
Par Amount	[4]			$ 12,117
Cost	[4]			11,967
Fair Value	[4]			$ 12,117
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Plastics Management, LLC | Health Care Providers & Services | S+500 | 1.00 |10.44 | 8/26/2021 | 8/18/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	500%
Floor	[4]	1%
Interest Rate	[4],[6]	10.44%
Acquisition Date	[4]	Aug. 26, 2021
Maturity Date	[4]	Aug. 18, 2027
Par Amount	[4]	$ 15,096
Cost	[4]	14,942
Fair Value	[4]	$ 15,096
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1.00 | 11.40 | 8/20/2021 | 8/12/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	575%
Floor	[4]	1%
Interest Rate	[4],[6]	11.40%
Acquisition Date	[4]	Aug. 20, 2021
Maturity Date	[4]	Aug. 12, 2026
Par Amount	[4]	$ 15,561
Cost	[4]	15,415
Fair Value	[4]	$ 15,561
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1.00% | 10.59% | 8/20/2021 | 8/12/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			1%
Interest Rate	[4],[5]			10.59%
Acquisition Date	[4]			Aug. 20, 2021
Maturity Date	[4]			Aug. 12, 2026
Par Amount	[4]			$ 15,680
Cost	[4]			15,499
Fair Value	[4]			$ 15,680
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | RSC Acquisition Inc. | Insurance | S+550 | 0.75% | 9.26% | 10/5/2020 | 11/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			0.75%
Interest Rate	[4],[5]			9.26%
Acquisition Date	[4]			Oct. 05, 2020
Maturity Date	[4]			Nov. 01, 2026
Par Amount	[4]			$ 9,345
Cost	[4]			9,191
Fair Value	[4]			$ 9,345
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Revlon Consumer Products Corporation | Personal Products | P+475 | 2.75% | 12.25% | 5/7/2021 | 6/17/2023
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			475%
Floor	[4]			2.75%
Interest Rate	[4],[5]			12.25%
Acquisition Date	[4]			May 07, 2021
Maturity Date	[4]			Jun. 17, 2023
Par Amount	[4]			$ 13,905
Cost	[4]			13,876
Fair Value	[4]			$ 13,974
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | L+500 | 1.00% | 9.41% | 3/17/2020 | 3/13/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			500%
Floor	[4]			1%
Interest Rate	[4],[5]			9.41%
Acquisition Date	[4]			Mar. 17, 2020
Maturity Date	[4]			Mar. 13, 2026
Par Amount	[4]			$ 14,674
Cost	[4]			14,522
Fair Value	[4]			$ 14,674
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | S+500 | 1.00 | 10.47 | 3/17/2020 | 3/13/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	500%
Floor	[4]	1%
Interest Rate	[4],[6]	10.47%
Acquisition Date	[4]	Mar. 17, 2020
Maturity Date	[4]	Mar. 13, 2026
Par Amount	[4]	$ 14,524
Cost	[4]	14,406
Fair Value	[4]	$ 14,524
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management LLC | Health Care Providers & Services | S+600 | 1.00% | 10.84% | 6/3/2022 | 1/27/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			600%
Floor	[4]			1%
Interest Rate	[4],[5]			10.84%
Acquisition Date	[4]			Jun. 03, 2022
Maturity Date	[4]			Jan. 27, 2026
Par Amount	[4]			$ 1,901
Cost	[4]			1,884
Fair Value	[4]			$ 1,901
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+625 | 1.00 | 11.89 | 6/3/2022 | 1/27/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	625%
Floor	[4]	1%
Interest Rate	[4],[6]	11.89%
Acquisition Date	[4]	Jun. 03, 2022
Maturity Date	[4]	Jan. 27, 2026
Par Amount	[4]	$ 4,486
Cost	[4]	4,450
Fair Value	[4]	$ 4,397
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Spectrum Pharmaceuticals Inc. | Biotechnology | S+570 | 2.30% | 9.88% | 9/21/2022 | 9/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			570%
Floor	[4]			2.30%
Interest Rate	[4],[5]			9.88%
Acquisition Date	[4]			Sep. 21, 2022
Maturity Date	[4]			Sep. 01, 2027
Par Amount	[4]			$ 3,559
Cost	[4]			3,519
Fair Value	[4]			$ 3,524
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | SunMed Group Holdings LLC | Health Care Providers & Services | L+575 | 0.75% | 10.48% | 6/16/2021 | 6/16/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			0.75%
Interest Rate	[4],[5]			10.48%
Acquisition Date	[4]			Jun. 16, 2021
Maturity Date	[4]			Jun. 16, 2028
Par Amount	[4]			$ 7,929
Cost	[4]			7,815
Fair Value	[4]			$ 7,929
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | SunMed Group Holdings, LLC | Health Care Equipment & Supplies | S+550 | 0.75 | 10.99 | 6/16/2021 | 6/16/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	550%
Floor	[4]	0.75%
Interest Rate	[4],[6]	10.99%
Acquisition Date	[4]	Jun. 16, 2021
Maturity Date	[4]	Jun. 16, 2028
Par Amount	[4]	$ 7,623
Cost	[4]	7,527
Fair Value	[4]	$ 7,623
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | TAUC Management LLC | Health Care Providers & Services | L+525 | 1.00% | 9.98% | 2/12/2021 | 2/12/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			525%
Floor	[4]			1%
Interest Rate	[4],[5]			9.98%
Acquisition Date	[4]			Feb. 12, 2021
Maturity Date	[4]			Feb. 12, 2027
Par Amount	[4]			$ 9,013
Cost	[4]			8,912
Fair Value	[4]			$ 8,968
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | TAUC Management, LLC | Health Care Providers & Services | L+525 | 1.00 | 10.59 | 2/12/2021 | 2/12/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	525%
Floor	[4]	1%
Interest Rate	[4],[6]	10.59%
Acquisition Date	[4]	Feb. 12, 2021
Maturity Date	[4]	Feb. 12, 2027
Par Amount	[4]	$ 9,005
Cost	[4]	8,921
Fair Value	[4]	$ 8,375
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Tilley Distribution Inc. | Trading Companies & Distributors | S+550 | 1.00% | 10.14% | 12/8/2021 | 12/31/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			550%
Floor	[4]			1%
Interest Rate	[4],[5]			10.14%
Acquisition Date	[4]			Dec. 08, 2021
Maturity Date	[4]			Dec. 31, 2026
Par Amount	[4]			$ 12,762
Cost	[4]			12,633
Fair Value	[4]			$ 12,762
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Tilley Distribution, Inc. | Trading Companies & Distributors | S+600 | 1.00 | 11.54 | 12/8/2021 | 12/31/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	600%
Floor	[4]	1%
Interest Rate	[4],[6]	11.54%
Acquisition Date	[4]	Dec. 08, 2021
Maturity Date	[4]	Dec. 31, 2026
Par Amount	[4]	$ 12,526
Cost	[4]	12,419
Fair Value	[4]	$ 12,526
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Transportation Insight LLC | Road & Rail | L+450 | 1.00% | 8.91% | 10/27/2021 | 12/18/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			450%
Floor	[4]			1%
Interest Rate	[4],[5]			8.91%
Acquisition Date	[4]			Oct. 27, 2021
Maturity Date	[4]			Dec. 18, 2024
Par Amount	[4]			$ 4,198
Cost	[4]			4,150
Fair Value	[4]			$ 4,198
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Transportation Insight, LLC | Road & Rail | S+450 | 1.00 | 9.87 10/27/2021 | 12/18/2024
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	450%
Floor	[4]	1%
Interest Rate	[4],[6]	9.87%
Acquisition Date	[4]	Oct. 27, 2021
Maturity Date	[4]	Dec. 18, 2024
Par Amount	[4]	$ 5,581
Cost	[4]	5,536
Fair Value	[4]	$ 5,581
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | L+650 | 1.00% | 10.88% | 8/12/2021 | 8/13/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			650%
Floor	[4]			1%
Interest Rate	[4],[5]			10.88%
Acquisition Date	[4]			Aug. 12, 2021
Maturity Date	[4]			Aug. 13, 2027
Par Amount	[4]			$ 7,877
Cost	[4]			7,717
Fair Value	[4]			$ 7,877
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | S+625 | 1.00 | 11.67 | 8/12/2021 | 8/13/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	625%
Floor	[4]	1%
Interest Rate	[4],[6]	11.67%
Acquisition Date	[4]	Aug. 12, 2021
Maturity Date	[4]	Aug. 13, 2027
Par Amount	[4]	$ 7,574
Cost	[4]	7,442
Fair Value	[4]	$ 7,574
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Vapotherm Inc. | Health Care Equipment & Supplies | S+830 | 1.00% | 12.58% | 2/18/2022 | 2/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			830%
Floor	[4]			1%
Interest Rate	[4],[5],[6],[15]			12.58%
Acquisition Date	[4]			Feb. 18, 2022
Maturity Date	[4]			Feb. 01, 2027
Par Amount	[4]			$ 12,070
Cost	[4]			12,076
Fair Value	[4]			$ 12,131
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Vapotherm, Inc. | Health Care Equipment & Supplies | S+930 | 1.00 | 14.73 | 2/18/2022 | 2/1/2027
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	930%
Floor	[4]	1%
Interest Rate	[4],[6],[15]	14.73%
Acquisition Date	[4]	Feb. 18, 2022
Maturity Date	[4]	Feb. 01, 2027
Par Amount	[4]	$ 12,901
Cost	[4]	13,052
Fair Value	[4]	$ 13,094
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Vessco Midco Holdings LLC | Water Utilities | L+450 | 1.00% | 7.87% | 9/3/2021 | 11/2/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			450%
Floor	[4]			1%
Interest Rate	[4],[5]			7.87%
Acquisition Date	[4]			Sep. 03, 2021
Maturity Date	[4]			Nov. 02, 2026
Par Amount	[4]			$ 2,207
Cost	[4]			2,189
Fair Value	[4]			$ 2,206
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | Vessco Midco Holdings, LLC | Water Utilities | S+450 | 1.00 | 9.85 | 9/3/2021 | 11/2/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	450%
Floor	[4]	1%
Interest Rate	[4],[6]	9.85%
Acquisition Date	[4]	Sep. 03, 2021
Maturity Date	[4]	Nov. 02, 2026
Par Amount	[4]	$ 5,504
Cost	[4]	5,458
Fair Value	[4]	$ 5,504
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | World Insurance Associates LLC | Insurance | S+575 | 1.00% | 10.07% | 10/12/2020 | 4/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			575%
Floor	[4]			1%
Interest Rate	[4],[5]			10.07%
Acquisition Date	[4]			Oct. 12, 2020
Maturity Date	[4]			Apr. 01, 2026
Par Amount	[4]			$ 19,614
Cost	[4]			19,261
Fair Value	[4]			$ 18,829
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | World Insurance Associates, LLC | Insurance | S+575 | 1.00 | 11.14 | 10/12/2020 | 4/1/2026
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	575%
Floor	[4]	1%
Interest Rate	[4],[6]	11.14%
Acquisition Date	[4]	Oct. 12, 2020
Maturity Date	[4]	Apr. 01, 2026
Par Amount	[4]	$ 19,217
Cost	[4]	19,199
Fair Value	[4]	$ 19,217
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | iCIMS Inc. | Software | S+725 | 0.75% | 11.52% | 8/18/2022 | 8/18/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]			725%
Floor	[4]			0.75%
Interest Rate	[4],[5],[16]			11.52%
Acquisition Date	[4]			Aug. 18, 2022
Maturity Date	[4]			Aug. 18, 2028
Par Amount	[4]			$ 13,757
Cost	[4]			13,527
Fair Value	[4]			13,517
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans | iCIMS, Inc. | Software | S+725 | 0.75 | 12.63 | 8/18/2022 | 8/18/2028
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	725%
Floor	[4]	0.75%
Interest Rate	[4],[6],[16]	12.63%
Acquisition Date	[4]	Aug. 18, 2022
Maturity Date	[4]	Aug. 18, 2028
Par Amount	[4]	$ 14,084
Cost	[4]	13,877
Fair Value	[4]	14,084
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants
Summary of Investment Holdings [Line Items]
Cost		17,667		150
Fair Value		$ 13,369		$ 142
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Assertio Holdings, Inc. Common Stock | Pharmaceuticals | 7/31/2023
Summary of Investment Holdings [Line Items]
Acquisition Date	[17],[18]	Jul. 31, 2023
Par Amount	[17],[18]	$ 4,230
Cost	[17],[18]	17
Fair Value	[17],[18]	$ 11
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Centrexion Therapeutics Inc. Warrants | Pharmaceuticals | 6/28/2019
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]			Jun. 28, 2019
Par Amount	[18]			$ 56,483
Cost	[18]			27
Fair Value	[18]			$ 16
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | 6/28/2019
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]	Jun. 28, 2019
Par Amount	[18]	$ 56,483
Cost	[18]	27
Fair Value	[18]	$ 10
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Meditrina Inc. Warrants | Health Care Equipment & Supplies | 12/20/2022
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]			Dec. 20, 2022
Par Amount	[18]			$ 10,572
Cost	[18]			8
Fair Value	[18]			$ 8
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Meditrina, Inc. Warrants | Health Care Equipment & Supplies | 7/31/2023
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]	Dec. 20, 2022
Par Amount	[18]	$ 10,572
Cost	[18]	8
Fair Value	[18]	$ 7
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | 6/16/2023
Summary of Investment Holdings [Line Items]
Acquisition Date	[13],[18],[19]	Jun. 16, 2023
Par Amount	[13],[18],[19]	$ 0
Cost	[13],[18],[19]	17,489
Fair Value	[13],[18],[19]	$ 13,283
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Senseonics Holdings Inc. Common Stock | Health Care Equipment & Supplies | 7/25/2019
Summary of Investment Holdings [Line Items]
Acquisition Date	[8],[18]			Jul. 25, 2019
Par Amount	[8],[18]			$ 79,501
Cost	[8],[18]			23
Fair Value	[8],[18]			$ 82
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Senseonics Holdings, Inc. Common Stock | Health Care Equipment & Supplies | 7/25/2019
Summary of Investment Holdings [Line Items]
Acquisition Date	[9],[17],[18]	Jul. 25, 2019
Par Amount	[9],[17],[18]	$ 79,501
Cost	[9],[17],[18]	23
Fair Value	[9],[17],[18]	$ 48
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Spectrum Pharmaceuticals Inc. Warrants | Biotechnology | 9/21/2022
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]			Sep. 21, 2022
Par Amount	[18]			$ 53,930
Cost	[18]			17
Fair Value	[18]			$ 5
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Vapotherm Inc. | Health Care Equipment & Supplies | 2/18/2022
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]			Feb. 18, 2022
Par Amount	[18]			$ 12,960
Cost	[18]			75
Fair Value	[18]			$ 31
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants | Vapotherm, Inc. | Health Care Equipment & Supplies | 2/18/2022
Summary of Investment Holdings [Line Items]
Acquisition Date	[18]	Feb. 18, 2022
Par Amount	[18]	$ 17,156
Cost	[18]	103
Fair Value	[18]	$ 10
[1]Aggregate net unrealized depreciation for U.S. federal income tax purposes is $9,212; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $4,423 and $13,635, respectively, based on a tax cost of $523,431. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.[2]Aggregate net unrealized depreciation for U.S. federal income tax purposes is $927; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $5,202 and $6,129, respectively, based on a tax cost of $533,822. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.[3]Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.[4]Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.[5]Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate, the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.[6]Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate, the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of September 30, 2023.[7]AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.[8]Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (“1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 11.2% of the total assets of the Company.[9]Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 12.0% of the total assets of the Company.[10]BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.[11]Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.[12]AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and AmeriMark Intermediate Holdings, LLC are each co-Borrowers.[13]Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the period June 16, 2023 (date at which the Company became an Affiliated Person) through September 30, 2023 in these affiliated investments are as follows:[14]Investment is on non-accrual status.[15]Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.[16]iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.[17]Denotes a Level 1 investment.[18]Non-income producing security.[19]Through this entity and other intermediate entities, the Company owns approximately 6.5% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former AmeriMark Interactive, LLC.

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments 1	Sep. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	100%	100%
Health Care Providers & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	14.10%	12.40%
Insurance
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	12.80%	14.30%
Software
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	10.30%	9.80%
Diversified Consumer Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	9.30%	8%
Health Care Equipment & Supplies
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	7.20%	6.80%
Pharmaceuticals
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	6.70%	6.50%
Trading Companies & Distributors
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	4.80%	4.80%
Biotechnology
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	4.80%	5.20%
Life Sciences Tools & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	3%	2.90%
IT Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.70%
Wireless Telecommunication Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.70%
Leisure Equipment & Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.60%
Internet & Catalog Retail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.60%	3.80%
Diversified Financial Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.50%	2.40%
Personal Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.30%	4.90%
Building Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.10%	2.10%
Capital Markets
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.80%	1.40%
Internet Software & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.30%	1.30%
Packaged Foods & Meats
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.50%	1.50%
Specialty Retail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.10%	1.10%
Road & Rail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.10%	0.80%
Water Utilities
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.10%	0.40%
Professional Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.10%	1.10%
Health Care Technology
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	0.40%	0.50%

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Parethetical) - USD ($) $ in Thousands	4 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Tax Basis Of Investments Unrealized Appreciation Depreciation Net	$ 9,212	$ 9,212	$ 927
Tax Basis Of Investments Gross Unrealized Appreciation	4,423	4,423	5,202
Tax Basis Of Investments Gross Unrealized Depreciation	13,635	13,635	6,129
Tax Basis Of Investments Cost For Income Tax Purposes	$ 523,431	$ 523,431	$ 533,822
iCIMS, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		3.875%	3.875%
Vapotherm, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		9%	8%
Kaseya Inc [Member]
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		2.50%
ASC Holdco, LLC
Summary of Investment Holdings [Line Items]
Investment company percentage of ownership	6.50%	6.50%
BridgeBio Pharma, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		3%	3%
AmeriMark Interactive LLC
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK			8%
Investment, Affiliated Issuer, Noncontrolled [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	$ 14,413
Gross Additions	12,428
Gross Reductions	(12,146)
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	(1,130)
Fair Value at June 30, 2023	13,565	$ 13,565
Interest/ Dividend Income	13
Investment, Affiliated Issuer, Noncontrolled [Member] | OldcoAI LLC [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	8,243
Gross Additions	0
Gross Reductions	(11,318)
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	3,075
Fair Value at June 30, 2023	0	0
Interest/ Dividend Income	0
Investment, Affiliated Issuer, Noncontrolled [Member] | OldcoAI LLC One [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	0
Gross Additions	1,110
Gross Reductions	(828)
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	0
Fair Value at June 30, 2023	282	282
Interest/ Dividend Income	13
Investment, Affiliated Issuer, Noncontrolled [Member] | SLR-AMI Topco Blocker, LLC
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	6,170
Gross Additions	11,318
Gross Reductions	0
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	(4,205)
Fair Value at June 30, 2023	13,283	$ 13,283
Interest/ Dividend Income	$ 0

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 7,284	$ 5,428	$ 13,256	$ 14,418

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization

Organization	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) is a Delaware limited liability company formed on May 18, 2018. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (“the 1940 Act”). Furthermore, as the Company is an investment company, it applies the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company was formed primarily to provide investors with attractive long-term returns through investments made pursuant to the investment strategy of the Company described below (the Company’s investments in portfolio companies are referred to herein as “Portfolio Investments”). On October 5, 2018 (the “Initial Closing Date”), the Company closed on $326,000 in capital commitments. On March 12, 2019, the sale and issuance of 2,800,000 of the Company’s units (“Units”), at an aggregate purchase price of $28,000 ($10.00 per Unit) occurred and the Company commenced operations. As of September 30, 2023, $261,500 of capital commitments were drawn and $64,500 were unfunded. The Company has implemented a corporate lending strategy focused on sourcing, underwriting and managing a diverse portfolio of private senior secured loans primarily to upper middle market companies (generally, aggregate loan sizes of $100,000 to $300,000 to companies with earnings before interest, tax, depreciation and amortization (“EBITDA”) between approximately $25,000 and $100,000) across the United States. In addition to senior secured loans to upper middle market companies, the Company intends to invest a portion of its assets in non-traditional The offering period of the Company ended on April 5, 2019 (the “Offering Period”). The investment period of the Company ended on December 31, 2022. The term of the Company will be six years from the end of the Offering Period unless the Company is liquidated earlier as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”), but may be extended by the Company’s Board of Directors (the “Board”) for up to two consecutive one year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q S-X, In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of financial statements, have been included. The significant accounting policies consistently followed by the Company are: (a) Investment transactions are accounted for on the trade date; (b) In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows: (i) securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available and deemed to represent fair value under GAAP will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under GAAP). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation; (ii) exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes; (iii) short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and (iv) securities, loans or other instruments for which market quotes are not readily available or reliable under GAAP will be valued as described below: a. the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR responsible for the Portfolio Investment; b. preliminary valuation conclusions are then documented and discussed with senior management of the Adviser; c. the audit committee of the Board reviews the preliminary valuations of the Adviser and third-party valuation specialist, if any, and responds to the valuation recommendations to d. the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third-party valuation specialist, if any, which may from time to time be engaged by the Board. The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 2a-5. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: Level 1 Level 2 Level 3 In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. (c) Gains or losses on investments are calculated by using the specific identification method. (d) The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring (e) The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. (f) Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. (g) Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. (h) In accordance with Regulation S-X Consolidation (i) The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. (j) In accordance with ASC 835-30, (k) T he 946-20-25. (l) Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual non-accrual (m) The Company records expenses directly related to its organization as incurred. (n) The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Agreements and Related Party Tr

Agreements and Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Agreements And Related Party Transactions [Abstract]
Agreements and Related Party Transactions	Note 3. Agreements and Related Party Transactions The Company has entered into an investment management agreement with the Adviser (the “Investment Management Agreement”) pursuant to which it will pay management fees, administrative coordinator fees and incentive fees to the Adviser. The Company will pay the Adviser a fee for investment advisory and management services consisting of two components: a base management fee and an incentive fee. The Company will also pay the Adviser (in its capacity as Administrative Coordinator, defined herein) an administration fee for administrative and coordination services. The cost of the base management fee, the incentive fee, and the administration fee will be borne by the Unitholders. Management Fees and Administration Fees The Company will pay the Adviser a management fee (the “Management Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (each such date, the “Management Fee Calculation Date”), in an amount equal to 1.5% per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company plus (ii) the total amount of credit drawn on subscription credit facilities), and payable quarterly in arrears after such Management Fee Calculation Date. Pursuant to the Investment Management Agreement, the Adviser has also been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay the Administrative Coordinator, a fee (the “Administration Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08% per annum of the average Cost Basis (defined as the aggregate accreted and amortized cost of all Portfolio Investments, including any amounts reinvested in investments and the cost of investments acquired using leverage), as measured on the last day of the preceding quarter and the last day of the current quarter for the period ended and payable quarterly in arrears after such Administration Fee Calculation Date. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, non-investment-related Each of the Management Fee and the Administration Fee will be appropriately adjusted for any stub period. Such fees will be paid out of net current income and/or disposition proceeds or, to the extent such amounts are not available, from unfunded capital commitments that will be drawn down, or borrowings of the Company. In the event that the Adviser arranges for the Company to pay any portion of a placement fee to a placement agent, the amount of Management Fees otherwise payable shall be reduced by an amount equal to 100% of such payment to the placement agent. Incentive Fee The Company will make distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, warrant gains, prepayment fees and exit fees, other than Disposition Proceeds. The Adviser will apportion each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds. Amounts of Investment Proceeds apportioned to Unitholders will be divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority: (i) Disposition Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee, on the other hand, in the following amounts and order of priority: (A) Return of Capital Contributions (B) Unitholder Preferred Return (C) Adviser Catch Up to 15% t (D) 85%/15% Shares (ii) Current Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee, on the other hand, in the following amounts and order of priority: (A) Unitholder Preferred Return (B) Adviser Catch Up to 15% (C) 85%/15% Units In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceeds 20% of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation. The Adviser has the right with respect to all Unitholders, upon approval of the Company’s independent directors, to waive or reduce the incentive fee to which it is entitled. The Adviser may also elect not to receive all or any portion of the incentive fee that would otherwise be distributed to it, and may cause any or all amounts subsequently available for distribution to the Unitholders to be distributed to the Adviser until it has received the same aggregate amount of incentive fees had it not previously waived receipt of incentive fees. The Adviser will be entitled to withhold from any distributions, in its discretion, any required tax withholdings. Amounts of taxes paid or withheld from amounts otherwise distributable to a Unitholder will be deemed distributed for purposes of the calculations above. Upon liquidation of the Company, the Adviser will be required to restore funds to the Company for distribution to the Unitholders if and to the extent that the Adviser has received cumulative incentive fees in excess of the incentive fees that would have been payable to the Adviser on an aggregate basis covering all transactions of the Company; provided, however, that in no event will the Adviser be required to contribute an aggregate amount in excess of 100% of the net amount distributed to the Adviser (net of taxes) on account of its incentive fees. In addition, the Adviser will apply an interim incentive fee adjustment at the end of each fiscal year so that, in the event of any over-distribution of incentive fee to the Adviser (measured with respect to each Unitholder using the fair value of the Company’s portfolio at the end of the applicable fiscal year as if the Company were to liquidate on such date), future distributions that would, absent such interim incentive fee adjustment, otherwise be distributed to the Adviser as an incentive fee, shall be distributed to such Unitholder until such over-distribution (net of taxes payable by the Adviser with respect to such incentive fee) has been eliminated. For the three and nine months ended September 30, 2023, the Company incurred $1,102 and $3,238, respectively, in Management Fees, $105 and $315, respectively, in Administration Fees and $1,285 and $2,339, respectively, in incentive fees. For the three and nine months ended September 30, 2022, the Company incurred $1,010 and $2,770, respectively, in Management Fees, $102 and $283, respectively, in Administration Fees and $958 and $2,544, respectively, in Incentive Fees. The aggregate amount of certain operating expenses relating to Unitholders investing directly in the Company will not exceed the Operating Expense Cap, calculated as follows: (A) if the Company has less than or equal to $400,000 in capital commitments, an amount equal to the sum of (x) the product of the capital commitments and 0.0025 and (y) $1,250, or (B) if the Company has greater than $400,000 in capital commitments, $2,250. Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. For the avoidance of doubt, the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder. The Adviser or Administrative Coordinator and/or their affiliates has advanced organizational and offering expenses to the Company, which include organizational fees, costs, expenses and liabilities of the Company, including legal expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company (“Organizational Expenses”). The Adviser or Administrative Coordinator (or such affiliate) has been reimbursed by the Company for such advanced costs and expenses in an amount not to exceed $500. $308 of offering expenses were charged to capital and $84 of organizational costs were expensed in 2019.

Fair Value

Fair Value	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value	Note 4. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1. Level 2. a) Quoted prices for similar assets or liabilities in active markets; b) Quoted prices for identical or similar assets or liabilities in non-active c) Pricing models whose inputs are observable for substantially the full term of the asset or liability; and d) Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. Level 3. in When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022: Fair Value Measurements As of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ —  $ —  $ 500,850 $ 500,850 Common Equity/Equity Interests/Warrants 59 —  13,310 13,369 Total Investments $ 59 $ —  $ 514,160 $ 514,219 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2023, the fair value of the SPV Facility and the Subscription Facility would be $223,800 and $30,000, respectively. Fair Value Measurements As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ —  $ —  $ 532,753 $ 532,753 Common Equity/Equity Interests/Warrants 82 —  60 142 Total Investments $ 82 $ —  $ 532,813 $ 532,895 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at December 31, The following table provides a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Total gains or losses included in earnings: Net realized gain —  —  —  Net change in unrealized gain (loss) 5,793 (5,879 ) (86 ) Purchase of investment securities* 9,334 11,329 20,663 Proceeds from dispositions of investment securities (28,808 ) (17 ) (28,825 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, September 30, 2023 $ 500,850 $ 13,310 $ 514,160 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 5,959 $ (5,869 ) $ 90 Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 6 —  6 Net change in unrealized loss (3,995 ) (4,250 ) (8,245 ) Purchase of investment securities* 69,424 17,517 86,941 Proceeds from dispositions of investment securities (97,338 ) (17 ) (97,355 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, September 30, 2023 $ 500,850 $ 13,310 $ 514,160 Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized loss $ (3,643 ) $ (4,262 ) $ (7,905 ) * Includes PIK capitalization and accretion of discount The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2021 $ 439,661 $ 13 $ 439,674 Total gains or losses included in earnings: Net realized gain (loss) —  —  —  Net change in unrealized gain (loss) 340 (53 ) 287 Purchase of investment securities 188,107 100 188,207 Proceeds from dispositions of investment securities (95,355 ) —  (95,355 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 744 $ (53 ) $ 691 Quantitative Information about Level 3 Fair Value Measurements The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. Quantitative information about the Company’s Level 3 asset fair value measurements as of September 30, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 500,850 Income Approach Market Yield 10.1% - 16.8% (12.1%) Common Equity/Equity Interests/Warrants Asset $ 27 Market Approach Volatility 17.8% - 17.8% (17.8%) $ 13,283 EBITDA Multiple Comparable Multiple 6.25x-7.25x Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2022 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 532,753 Income Approach Market Yield 9.4% - 16.2% (11.4%) Common Equity/Equity Interests/Warrants Asset $ 60 Market Approach Volatility 26.0% - 26.0% (26.0%) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask inve

Debt

Debt	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Debt	Note 5. Debt SPV Facility . On February Subscription Facility The average annualized interest cost for borrowings for the nine months ended September 30, 2023 and the year ended December 31, 2022 was 8.03% and 4.67%, respectively. These costs are exclusive of other credit facility expenses such as unused fees and fees paid to the back-up

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6. Commitments and Contingencies The Company had unfunded debt commitments to various revolving and delayed-draw term loans. Th September 30, December 31, Outset Medical, Inc. $ 11,865 $ 11,865 Human Interest Inc. 6,799 6,799 Arcutis Biotherapeutics, Inc. 3,065 3,065 Ardelyx, Inc. 2,716 2,716 iCIMS, Inc. 2,555 3,867 Cerapedics, Inc. 2,424 2,424 Neuronetics, Inc. 1,964 —  High Street Buyer, Inc. 1,890 2,797 Maurices, Incorporated 1,640 2,733 RxSense Holdings, LLC 1,558 1,558 Enverus Holdings, Inc. 1,545 1,251 Nexus Intermediate III, LLC (Vortex) 1,264 1,264 Kid Distro Holdings, LLC 1,121 1,121 GSM Acquisition Corp. 1,101 1,101 Foundation Consumer Brands, LLC 967 967 Basic Fun, Inc. 960 1,195 Ultimate Baked Goods Midco LLC 753 578 Kaseya, Inc. 625 1,315 MRI Software LLC. 577 577 ENS Holdings III Corp. & ES Opco USA LLC 574 179 SunMed Group Holdings, LLC 515 268 Transportation Insight, LLC 454 1,860 Vessco Midco Holdings, LLC 417 4,969 TAUC Management, LLC 385 385 CC SAG Holdings Corp. (Spectrum Automotive) 174 6,568 Accession Risk Management Group, Inc. —  10,328 Oral Surgery Partners Holdings, LLC —  3,277 Glooko, Inc. —  3,185 Plastics Management, LLC —  3,095 Spectrum Pharmaceuticals, Inc. —  2,966 Southern Orthodontic Partners Management, LLC —  2,605 Pediatric Home Respiratory Services, LLC —  2,451 Orthopedic Care Partners Management, LLC —  2,200 Erie Construction Mid-west, —  1,593 Meditrina, Inc. —  1,212 Tilley Chemical Buyer, Inc. —  670 Peter C. Foy & Associates Insurance Services, LLC —  570 Pinnacle Treatment Centers, Inc. —  520 Ivy Fertility Services, LLC —  499 BayMark Health Services, Inc. —  499 NAC Holdings Corporation —  470 Apex Service Partners, LLC —  345 All States Ag Parts, LLC —  172 World Insurance Associates, LLC —  135 Total Commitments $ 47,908 $ 98,214 The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. In the normal course of our business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance off-balance

Unitholders' Capital

Unitholders' Capital	9 Months Ended
	Sep. 30, 2023
Limited Liability Company (LLC) Members' Equity [Abstract]
Unitholders' Capital	Note 7. Unitholders’ Capital Transactions in Unitholders’ capital were as follows: Three months Three months Units at beginning of period 25,190,253 18,992,563 Units issued —  —  Units issued and outstanding at end of period 25,190,253 18,992,563 Nine months Nine months Units at beginning of period 18,992,563 17,137,275 Units issued 6,197,690 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563

Financial Highlights

Financial Highlights	9 Months Ended
	Sep. 30, 2023
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 8. Financial Highlights The following is a schedule of financial highlights for the nine months ended September 30, 2023 and September 30, 2022: Nine months Nine months Per Share Data: (a) Net asset value per Unit, beginning of period $ 10.33 $ 10.28 Net investment income 0.89 0.76 Net realized and unrealized gain (loss) (0.31 )* 0.06 Net increase in Unitholders’ capital resulting from operations 0.58 0.82 Distributions to Unitholders: From distributable earnings (0.27 ) (0.25 ) Net asset value per Unit, end of period $ 10.64 $ 10.85 Total Return (b)(c) 5.61 % 7.98 % Unitholders’ capital, end of period $ 267,973 $ 206,003 Units outstanding, end of period 25,190,253 18,992,563 Ratios to average net assets of Unitholders’ Capital (c): Net investment income 8.57 % 7.16 % Operating expenses 2.63 % 3.31 % Interest and other credit facility expenses 7.11 % 5.43 % Total expenses 9.74 % 8.74 % Average debt outstanding $ 274,782 $ 291,045 Portfolio turnover ratio 15.9 % 8.1 % (a) Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. (c) Not annualized for * Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9. Subsequent Events The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. On October 13, 2023, the Company delivered a capital drawdown notice to its investor, an investment fund created by a financial institution unaffiliated with the Company (the “Access Fund”), relating to the sale of approximately 1,500,000 Units, for an aggregate offering price of $16,300. The sale closed on October 27, 2023. The sale of Units is being made pursuant to a subscription agreement (the “Subscription Agreement”) and the LLC Agreement entered into by the Company and the Access Fund. Under the terms of the Subscription Agreement and the LLC Agreement, the Access Fund is required to fund drawdowns to purchase Units up to the amount of its capital commitment on an as-needed The issuance and sale of the Units are exempt from the registration requirements of the Securities Act, pursuant to Section 4(a)(2) thereof and Regulation D thereunder. On October 20, 2023, the SPV entered into the third amendment (the “Amendment”) to the SPV Facility. Pursuant to the Amendment, (i) commitments to the SPV Facility were reduced from $300,000 to approximately $261,388, as may be further adjusted per the terms of the SPV Facility, (ii) the final maturity date of the SPV Facility was extended from December 31, 2023 to August 15, 2024, and (iii) the general stated interest rate of the SPV Facility was decreased from SOFR plus 2.90% with respect to advances denominated in U.S. dollars and CDOR plus 2.90% with respect to advances denominated in Canadian dollars to SOFR plus 2.70% with respect to advances denominated in U.S. dollars and CDOR plus 2.70% with respect to advances denominated in Canadian dollars, among other non-material

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Summary of assets measured at fair value on a recurring basis	The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2023 and December 31, 2022: Fair Value Measurements As of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ —  $ —  $ 500,850 $ 500,850 Common Equity/Equity Interests/Warrants 59 —  13,310 13,369 Total Investments $ 59 $ —  $ 514,160 $ 514,219 Fair Value Measurements As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ —  $ —  $ 532,753 $ 532,753 Common Equity/Equity Interests/Warrants 82 —  60 142 Total Investments $ 82 $ —  $ 532,813 $ 532,895
Summary of the changes in fair value of level 3 assets	The following table provides a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Total gains or losses included in earnings: Net realized gain —  —  —  Net change in unrealized gain (loss) 5,793 (5,879 ) (86 ) Purchase of investment securities* 9,334 11,329 20,663 Proceeds from dispositions of investment securities (28,808 ) (17 ) (28,825 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, September 30, 2023 $ 500,850 $ 13,310 $ 514,160 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 5,959 $ (5,869 ) $ 90 Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 6 —  6 Net change in unrealized loss (3,995 ) (4,250 ) (8,245 ) Purchase of investment securities* 69,424 17,517 86,941 Proceeds from dispositions of investment securities (97,338 ) (17 ) (97,355 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, September 30, 2023 $ 500,850 $ 13,310 $ 514,160 Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized loss $ (3,643 ) $ (4,262 ) $ (7,905 ) * Includes PIK capitalization and accretion of discount The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2021 $ 439,661 $ 13 $ 439,674 Total gains or losses included in earnings: Net realized gain (loss) —  —  —  Net change in unrealized gain (loss) 340 (53 ) 287 Purchase of investment securities 188,107 100 188,207 Proceeds from dispositions of investment securities (95,355 ) —  (95,355 ) Transfers into Level 3 —  —  —  Transfers out of Level 3 —  —  —  Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 744 $ (53 ) $ 691
Summary of quantitative information about the company's level 3 asset fair value measurements	Quantitative information about the Company’s Level 3 asset fair value measurements as of September 30, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 500,850 Income Approach Market Yield 10.1% - 16.8% (12.1%) Common Equity/Equity Interests/Warrants Asset $ 27 Market Approach Volatility 17.8% - 17.8% (17.8%) $ 13,283 EBITDA Multiple Comparable Multiple 6.25x-7.25x Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2022 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 532,753 Income Approach Market Yield 9.4% - 16.2% (11.4%) Common Equity/Equity Interests/Warrants Asset $ 60 Market Approach Volatility 26.0% - 26.0% (26.0%)

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Summary of unfunded commitments	The Company had unfunded debt commitments to various revolving and delayed-draw term loans. Th September 30, December 31, Outset Medical, Inc. $ 11,865 $ 11,865 Human Interest Inc. 6,799 6,799 Arcutis Biotherapeutics, Inc. 3,065 3,065 Ardelyx, Inc. 2,716 2,716 iCIMS, Inc. 2,555 3,867 Cerapedics, Inc. 2,424 2,424 Neuronetics, Inc. 1,964 —  High Street Buyer, Inc. 1,890 2,797 Maurices, Incorporated 1,640 2,733 RxSense Holdings, LLC 1,558 1,558 Enverus Holdings, Inc. 1,545 1,251 Nexus Intermediate III, LLC (Vortex) 1,264 1,264 Kid Distro Holdings, LLC 1,121 1,121 GSM Acquisition Corp. 1,101 1,101 Foundation Consumer Brands, LLC 967 967 Basic Fun, Inc. 960 1,195 Ultimate Baked Goods Midco LLC 753 578 Kaseya, Inc. 625 1,315 MRI Software LLC. 577 577 ENS Holdings III Corp. & ES Opco USA LLC 574 179 SunMed Group Holdings, LLC 515 268 Transportation Insight, LLC 454 1,860 Vessco Midco Holdings, LLC 417 4,969 TAUC Management, LLC 385 385 CC SAG Holdings Corp. (Spectrum Automotive) 174 6,568 Accession Risk Management Group, Inc. —  10,328 Oral Surgery Partners Holdings, LLC —  3,277 Glooko, Inc. —  3,185 Plastics Management, LLC —  3,095 Spectrum Pharmaceuticals, Inc. —  2,966 Southern Orthodontic Partners Management, LLC —  2,605 Pediatric Home Respiratory Services, LLC —  2,451 Orthopedic Care Partners Management, LLC —  2,200 Erie Construction Mid-west, —  1,593 Meditrina, Inc. —  1,212 Tilley Chemical Buyer, Inc. —  670 Peter C. Foy & Associates Insurance Services, LLC —  570 Pinnacle Treatment Centers, Inc. —  520 Ivy Fertility Services, LLC —  499 BayMark Health Services, Inc. —  499 NAC Holdings Corporation —  470 Apex Service Partners, LLC —  345 All States Ag Parts, LLC —  172 World Insurance Associates, LLC —  135 Total Commitments $ 47,908 $ 98,214

Unitholders' Capital (Tables)

Unitholders' Capital (Tables)	9 Months Ended
	Sep. 30, 2023
Limited Liability Company (LLC) Members' Equity [Abstract]
Summary of limited liability company unit holders capital	Transactions in Unitholders’ capital were as follows: Three months Three months Units at beginning of period 25,190,253 18,992,563 Units issued —  —  Units issued and outstanding at end of period 25,190,253 18,992,563 Nine months Nine months Units at beginning of period 18,992,563 17,137,275 Units issued 6,197,690 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563

Financial Highlights (Tables)

Financial Highlights (Tables)	9 Months Ended
	Sep. 30, 2023
Investment Company, Financial Highlights [Abstract]
Summary of investment company, financial highlights	The following is a schedule of financial highlights for the nine months ended September 30, 2023 and September 30, 2022: Nine months Nine months Per Share Data: (a) Net asset value per Unit, beginning of period $ 10.33 $ 10.28 Net investment income 0.89 0.76 Net realized and unrealized gain (loss) (0.31 )* 0.06 Net increase in Unitholders’ capital resulting from operations 0.58 0.82 Distributions to Unitholders: From distributable earnings (0.27 ) (0.25 ) Net asset value per Unit, end of period $ 10.64 $ 10.85 Total Return (b)(c) 5.61 % 7.98 % Unitholders’ capital, end of period $ 267,973 $ 206,003 Units outstanding, end of period 25,190,253 18,992,563 Ratios to average net assets of Unitholders’ Capital (c): Net investment income 8.57 % 7.16 % Operating expenses 2.63 % 3.31 % Interest and other credit facility expenses 7.11 % 5.43 % Total expenses 9.74 % 8.74 % Average debt outstanding $ 274,782 $ 291,045 Portfolio turnover ratio 15.9 % 8.1 % (a) Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. (c) Not annualized for * Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Organization - Additional Infor

Organization - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands			9 Months Ended
	Mar. 12, 2019	Oct. 05, 2018	Sep. 30, 2023
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investment company committed capital		$ 326,000
Stock issued during period shares new issues	2,800,000
Stock issued during period value new issues	$ 28,000
Share price	$ 10
Investment company funded capital commitments			$ 261,500
Investment company unfunded capital commitments			64,500
Minimum [Member] | Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			100,000
Earnings before interest tax depreciation and amortization			25,000
Maximum [Member] | Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			300,000
Earnings before interest tax depreciation and amortization			$ 100,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Percentage of excise tax	4%

Agreements and Related Party _2

Agreements and Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		9 Months Ended
		Oct. 05, 2018	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Agreements And Related Party Transactions [Line Items]
Investment company, total return	[1],[2],[3]				5.61%	7.98%
Percentage of reimbursement of distributions by adviser upon liquidation			100%		100%
Management fee expense			$ 1,102	$ 1,010	$ 3,238	$ 2,770
Administrative fees expense			105	102	315	283
Incentive fee expense			$ 1,285	958	$ 2,339	2,544
Investment company committed capital		$ 326,000
First, Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of current proceeds to unitholders					100%
Second., Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of total amount distributed to unitholders and advisers					15%
Percentage of Current Proceeds to Advisers					80%
Third Order of Priority Return of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders					85%
Percentage of distribution to adviser as an incentive fee					15%
Capital Commitment Condition One [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital					$ 400,000
Multiplier to capital commitment			0.0025		0.0025
Aggregate operating expenses relating to unitholders			$ 1,250		$ 1,250
Capital Commitment Condition Two [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital					400,000
Aggregate operating expenses relating to unitholders			2,250		$ 2,250
First Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders					100%
Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders					100%
Third Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to advisers					80%
Percentage of total amount distributed to unitholders and advisers					15%
Fourth Order Of Priority Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders					85%
Percentage of distribution to adviser as an incentive fee					15%
Minimum [Member] | Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Investment company, total return					6%
Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Management fee expense			1,102	1,010	$ 3,238	2,770
Administrative fees expense			105	102	315	283
Incentive fee expense			1,285	$ 958	2,339	$ 2,544
Reimbursement of organizational and offering expenses			500		500
Reimbursement of offering expenses			308		308
Reimbursement of organizational expenses			$ 84		$ 84
Management Fee [Member] | Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate					1.50%
Percentage of payment to placement agent					100%
Administration Fee [Member] | Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate					0.08%
[1]Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load.[2]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.[3]Not annualized for periods less than one year.

Fair Value - Summary of Assets

Fair Value - Summary of Assets Measured At Fair Value On A Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 514,219	$ 532,895
Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	500,850	532,753
Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	13,369	142
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	59	82
Fair Value, Inputs, Level 1 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 1 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	59	82
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	514,160	532,813
Fair Value, Inputs, Level 3 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	500,850	532,753
Fair Value, Inputs, Level 3 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 13,310	$ 60

Fair Value - Summary of The Cha

Fair Value - Summary of The Changes In Fair Value Of Level 3 Assets (Detail) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023		Sep. 30, 2023		Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 522,408		$ 532,813		$ 439,674
Net realized gain (loss)	0		6		0
Net change in unrealized gain (loss)	(86)		(8,245)		287
Purchase of investment securities	20,663	[1]	86,941	[1]	188,207
Proceeds from dispositions of investment securities	(28,825)		(97,355)		(95,355)
Transfers into Level 3	0		0		0
Transfers out of Level 3	0		0		0
Closing balance	514,160		514,160		532,813
Net change in unrealized gain (loss)	90		(7,905)		691
Bank Debt/Senior Secured Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	514,531		532,753		439,661
Net realized gain (loss)	0		6		0
Net change in unrealized gain (loss)	5,793		(3,995)		340
Purchase of investment securities	9,334	[1]	69,424	[1]	188,107
Proceeds from dispositions of investment securities	(28,808)		(97,338)		(95,355)
Transfers into Level 3	0		0		0
Transfers out of Level 3	0		0		0
Closing balance	500,850		500,850		532,753
Net change in unrealized gain (loss)	5,959		(3,643)		744
Common Equity/Equity Interests/Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	7,877		60		13
Net realized gain (loss)	0		0		0
Net change in unrealized gain (loss)	(5,879)		(4,250)		(53)
Purchase of investment securities	11,329	[1]	17,517	[1]	100
Proceeds from dispositions of investment securities	(17)		(17)		0
Transfers into Level 3	0		0		0
Transfers out of Level 3	0		0		0
Closing balance	13,310		13,310		60
Net change in unrealized gain (loss)	$ (5,869)		$ (4,262)		$ (53)
[1]Includes PIK capitalization and accretion of discount

Fair Value - Summary of Quantit

Fair Value - Summary of Quantitative Information About The Company's Level 3 Asset Fair Value Measurements (Detail) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 500,850	$ 532,753
Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	27	$ 60
Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 13,283
Minimum [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	10.1	9.4
Minimum [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.8	26
Minimum [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6.25
Maximum [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	16.8	16.2
Maximum [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.8	26
Maximum [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	7.25
Weighted Average [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	12.1	11.4
Weighted Average [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.8	26
Weighted Average [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6.75

Fair Value - Additional informa

Fair Value - Additional information (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
SPV Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 223,800	$ 267,726
Subscription Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 30,000	$ 70,400

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Dec. 28, 2022

Aug. 18, 2021

Mar. 31, 2019

Mar. 31, 2019

Sep. 30, 2023

Dec. 31, 2022

Aug. 03, 2022

Nov. 02, 2021

Oct. 04, 2021

Jul. 16, 2021

Mar. 05, 2021

Feb. 27, 2021

Nov. 18, 2019

Jun. 24, 2019

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 35,000

$ 35,000

Long term debt weighted average interest over a period of time

8.03%

4.67%

Line of credit facility, average outstanding amount

$ 338,126

$ 343,350

Subscription Facility [Member]

Line of Credit Facility [Line Items]

Long-Term Line of Credit

29,943

70,215

SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 200,000

$ 300,000

$ 275,000

$ 125,000

$ 100,000

$ 75,000

Long-Term Line of Credit

223,452

$ 266,334

Minimum [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

100,000

100,000

Maximum [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

400,000

400,000

East West Bank [Member] | Subscription Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 75,000

$ 35,000

$ 35,000

$ 100,000

$ 75,000

$ 50,000

Long-Term Line of Credit

30,000

Line of credit facility, expiration date

Dec. 31, 2023

London Interbank Offered Rate (LIBOR) [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.90%

Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | East West Bank [Member] | Subscription Facility [Member]

Line of Credit Facility [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.80%

JPMorgan Chase Bank [Member] | SCP Private Credit Income BDC SPV LLC [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

0.875%

Long-Term Line of Credit

$ 223,800

Line of credit facility, expiration date

Dec. 31, 2023

Dec. 31, 2023

Commitments and Contingencies -

Commitments and Contingencies - Summary of Unfunded Commitments (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 47,908	$ 98,214
Outset Medical, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	11,865	11,865
Human Interest Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	6,799	6,799
Arcutis Biotherapeutics, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	3,065	3,065
Ardelyx, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,716	2,716
iCIMS, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,555	3,867
Cerapedics, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,424	2,424
Neuronetics, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,964	0
High Street Buyer, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,890	2,797
Maurices, Incorporated
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,640	2,733
RxSense Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,558	1,558
Enverus Holdings, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,545	1,251
Nexus Intermediate III, LLC (Vortex)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,264	1,264
Kid Distro Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,121	1,121
GSM Acquisition Corp.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,101	1,101
Foundation Consumer Brands, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	967	967
Basic Fun, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	960	1,195
Ultimate Baked Goods Midco LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	753	578
Kaseya, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	625	1,315
MRI Software LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	577	577
ENS Holdings III Corp. & ES Opco USA LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	574	179
SunMed Group Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	515	268
Transportation Insight, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	454	1,860
Vessco Midco Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	417	4,969
TAUC Management, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	385	385
CC SAG Holdings Corp. (Spectrum Automotive)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	174	6,568
Accession Risk Management Group, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	10,328
Oral Surgery Partners Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	3,277
Glooko, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	3,185
Plastics Management, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	3,095
Spectrum Pharmaceuticals, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	2,966
Southern Orthodontic Partners Management, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	2,605
Pediatric Home Respiratory Services, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	2,451
Orthopedic Care Partners Management, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	2,200
Erie Construction Mid-west, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,593
Meditrina, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,212
Tilley Chemical Buyer, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	670
Peter C. Foy & Associates Insurance Services, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	570
Pinnacle Treatment Centers, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	520
Ivy Fertility Services, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	499
BayMark Health Services, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	499
NAC Holdings Corporation
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	470
Apex Service Partners, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	345
All States Ag Parts, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	172
World Insurance Associates, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 0	$ 135

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Unfunded commitments	$ 47,908	$ 98,214
Revolving Term Loans [Member]
Unfunded commitments	$ 47,908	$ 98,214

Unitholders' Capital - Summary

Unitholders' Capital - Summary of Limited Liability Company Unit Holders Capital (Detail) - shares		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Schedule Of Members Equity [Line Items]
Units at beginning of period		25,190,253	18,992,563	18,992,563	17,137,275
Units issued		0	0	6,197,690	1,855,288
Units issued and outstanding at end of period	[1]	25,190,253	18,992,563	25,190,253	18,992,563
[1]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.

Financial Highlights - Summary

Financial Highlights - Summary of Investment Company, Financial Highlights (Detail) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
		Sep. 30, 2023		Sep. 30, 2022
Per Share Data:
Net asset value per Unit, beginning of period	[1]	$ 10.33		$ 10.28
Net investment income	[1]	0.89		0.76
Net realized and unrealized gain (loss)	[1]	(0.31)	[2]	0.06
Net increase in Unitholders' capital resulting from operations	[1]	0.58		0.82
Distributions to Unitholders:
From distributable earnings	[1]	(0.27)		(0.25)
Net asset value per Unit, end of period	[1]	$ 10.64		$ 10.85
Total Return	[1],[3],[4]	5.61%		7.98%
Unitholders' capital, end of period	[1]	$ 267,973		$ 206,003
Units issued and outstanding at end of period	[1]	25,190,253		18,992,563
Ratios to average net assets of Unitholders' Capital:
Net investment income	[1],[4]	8.57%		7.16%
Operating expenses	[1],[4]	2.63%		3.31%
Interest and other credit facility expenses	[1],[4]	7.11%		5.43%
Total expenses	[1],[4]	9.74%		8.74%
Average debt outstanding	[1],[4]	$ 274,782		$ 291,045
Portfolio turnover ratio	[1],[4]	15.90%		8.10%
[1]Calculated using the average Units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2023 and September 30, 2022 were 24,077,997 and 17,898,419, respectively.[2]Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.[3]Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load.[4]Not annualized for periods less than one year.

Financial Highlights - Summar_2

Financial Highlights - Summary of Investment Company, Financial Highlights (Parenthetical) (Detail) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Weighted average limited liability company units outstanding	24,077,997	17,898,419

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($) $ in Thousands	Oct. 20, 2023	Oct. 13, 2023	Mar. 12, 2019
Subsequent Event [Line Items]
Stock issued during period shares new issues			2,800,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock issued during period shares new issues		1,500,000
Aggregate offering price		$ 16,300
SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Line of credit facility, expiration date	Aug. 15, 2024
Minimum [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Line of credit facility, increase (decrease), net	$ 261,388
Minimum [Member] | Canadian Dollar Offered Rate [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument, basis spread on variable rate	2.70%
Minimum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument, basis spread on variable rate	2.70%
Maximum [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Line of credit facility, increase (decrease), net	$ 300,000
Maximum [Member] | Canadian Dollar Offered Rate [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument, basis spread on variable rate	2.90%
Maximum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | SPV Facility [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument, basis spread on variable rate	2.90%